0001415889-19-000786.txt : 20190621 0001415889-19-000786.hdr.sgml : 20190621 20190621200822 ACCESSION NUMBER: 0001415889-19-000786 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190613 FILED AS OF DATE: 20190621 DATE AS OF CHANGE: 20190621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BORKOWSKI EDWARD CENTRAL INDEX KEY: 0001197542 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37853 FILM NUMBER: 19913051 MAIL ADDRESS: STREET 1: 1500 CORPORATE DRIVE STREET 2: SUITE 400 CITY: CANONSBURG STATE: PA ZIP: 15317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AzurRx BioPharma, Inc. CENTRAL INDEX KEY: 0001604191 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 BUSINESS PHONE: 646-699-7855 MAIL ADDRESS: STREET 1: 760 PARKSIDE AVENUE STREET 2: SUITE 304 CITY: BROOKLYN STATE: NY ZIP: 11226 FORMER COMPANY: FORMER CONFORMED NAME: BioPharma d'Azur, Inc. DATE OF NAME CHANGE: 20140331 4/A 1 form4a-06212019_050608.xml X0306 4/A 2019-06-13 2019-06-17 0001604191 AzurRx BioPharma, Inc. AZRX 0001197542 BORKOWSKI EDWARD SUITE 304 BROOKLYN NY 11226 true false false false Options 1.75 2019-06-13 4 A 0 30000 0 A 2024-06-13 Common Stock 30000 30000 D Options will vest in quarterly installments over a one-year period beginning on June 30, 2019. /s/ Maged Shenouda, Attorney-in-Fact 2019-06-21